Cognition Therapeutics (CGTX)
(Delayed Data from NSDQ)
$0.60 USD
+0.01 (1.84%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $0.60 0.00 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Cognition Therapeutics, Inc. (CGTX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.20 | $11.00 | $1.00 | 950.85% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Cognition Therapeutics, Inc. comes to $6.20. The forecasts range from a low of $1.00 to a high of $11.00. The average price target represents an increase of 950.85% from the last closing price of $0.59.
Analyst Price Targets (5 )
Broker Rating
Cognition Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 2 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.67 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | B. Riley Securities | Mayank Mamtani | Strong Buy | Hold |
7/31/2024 | LadenburgThalmann | Aydin Huseynov | Strong Buy | Strong Buy |
7/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/6/2024 | Chardan Capital Markets | Daniil Gataulin | Not Available | Strong Buy |
5/29/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 5 |
Average Target Price | $6.20 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | -0.19 |
CGTX FAQs
Cognition Therapeutics, Inc. (CGTX) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Cognition Therapeutics, Inc. (CGTX) is $6.20. The current on short-term price targets is based on 4 reports.
The forecasts for Cognition Therapeutics, Inc. (CGTX) range from a low of $1 to a high of $11. The average price target represents a increase of $933.33 from the last closing price of $.60.
The current UPSIDE for Cognition Therapeutics, Inc. (CGTX) is 933.33%
Based on short-term price targets offered by five analysts, the average price target for Cognition Therapeutics, Inc. comes to $6.20. The forecasts range from a low of $1.00 to a high of $11.00. The average price target represents an increase of 950.85% from the last closing price of $0.59.